SpinalMotion Inc.

Mounting clinical evidence supporting the use of artificial spinal discs, combined with an aging population and the clear benefits patients get from these devices compared with traditional spinal fusi

FDA report on underrepresented subpopulations FDA issued a report to Congress on July 5 called “FDA Report Ensuring Access to Adequate Information on Medical Products for All With a Special Focus

510(k) modifications workshop FDA will hold a public workshop May 17 in Silver Spring, Md., to discuss FDA’s “past, present and future policy” on when manufacturers should submit a new 510(k) for a ch

While the spine market has been in the doldrums since late 2010 when 20% of spine procedures were wiped out by payor pushback, there may be a lot more going on in this $7 billion global market than in